Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain

This study is currently recruiting participants.
Verified April 2013 by Pfizer
Sponsor:
Information provided by (Responsible Party):
Pfizer
ClinicalTrials.gov Identifier:
NCT01455415
First received: October 17, 2011
Last updated: May 16, 2013
Last verified: April 2013
  Purpose

This study is to test the effectiveness of pregabalin in treating nerve pain caused by diabetes. The suitable subjects will be patients who also use an non-steroid anti-inflammatory drug for another pain which is not related to the diabetic nerve pain.


Condition Intervention Phase
Painful Diabetic Peripheral Neuropathy
Drug: pregabalin
Drug: placebo
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
Official Title: A Study Of Pregabalin In The Treatment Of Subjects With Painful Diabetic Peripheral Neuropathy With Background Treatment Of NSAID For Other Pain Conditions

Resource links provided by NLM:


Further study details as provided by Pfizer:

Primary Outcome Measures:
  • Endpoint mean pain score, based on the mean of the last 7 daily pain numeric rating scale (NRS) scores from the daily pain diaries while receiving study medication in each treatment period [ Time Frame: 6 week ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Proportions of 30% and 50% pain responders using NRS scores from the daily pain diary (Pain Diary) [ Time Frame: 6 week ] [ Designated as safety issue: No ]
  • Patient Global Impression of Change assessed at the end of Period 1 (PGIC) [ Time Frame: 6 week ] [ Designated as safety issue: No ]
  • Daily Sleep Interference Rating Scale (Sleep Diary) [ Time Frame: 6 week ] [ Designated as safety issue: No ]
  • Quality of life using Norfolk Quality of Life Questionnaire - Diabetic Neuropathy (QoL DN) [ Time Frame: 6 week ] [ Designated as safety issue: No ]
  • European Quality of Life in 5 Dimensions (EQ 5D) [ Time Frame: 6 week ] [ Designated as safety issue: No ]
  • Pain severity and impact using the Brief Pain Inventory - short form (BPI sf) [ Time Frame: 6 week ] [ Designated as safety issue: No ]
  • Anxiety and depression using the Hospital Anxiety and Depression Scale (HADS) [ Time Frame: 6 week ] [ Designated as safety issue: No ]

Estimated Enrollment: 300
Study Start Date: December 2011
Estimated Study Completion Date: March 2014
Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1: Pregabalin Drug: pregabalin
150 - 300 mg/day in divided dose (3 time a day) for 6 weeks
Placebo Comparator: 2: Placebo Drug: placebo
matching placebo 3 time a day

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Type 1 or 2 diabetes with painful neuropathy
  • Currently treated with one NSAID (including COX 2 inhibitors) for a co morbid pain condition with a regular dose
  • Meet pre-defined level of pain severity at entrance

Exclusion Criteria:

  • History of failed pregabalin treatment due to lack of efficacy at therapeutic dose
  • Participated in a previous or ongoing pregabalin clinical trial
  • Neurologic disorders unrelated to diabetic neuropathy that may confound the assessment of distal neuropathic pain
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01455415

Contacts
Contact: Pfizer CT.gov Call Center 1-800-718-1021

  Hide Study Locations
Locations
United States, Arizona
Dedicated Clinical Research Recruiting
Goodyear, Arizona, United States, 85395
Clinical Research Consortium Recruiting
Phoenix, Arizona, United States, 85004
Precision Trials Recruiting
Phoenix, Arizona, United States, 85032
The Office of Joshua D. Holland, M.D. Recruiting
Phoenix, Arizona, United States, 85053
Advanced Podiatry Recruiting
Phoenix, Arizona, United States, 85032
Clinical Research Consortium Arizona Recruiting
Phoenix, Arizona, United States, 85003
Genova Clinical Research Recruiting
Tucson, Arizona, United States, 85704
United States, California
Neuro-Pain Medical Center Recruiting
Fresno, California, United States, 93710
Center for United Research, Inc. Recruiting
Lakewood, California, United States, 90712
IDS Pharmacy Recruiting
Los Angeles, California, United States, 90033
HealthCare Partners Medical Group Recruiting
Los Angeles, California, United States, 90015
University of Southern California Recruiting
Los Angeles, California, United States, 90033
United States, Connecticut
Neurological Group, PC Recruiting
New London, Connecticut, United States, 06320
Coastal Connecticut Research, LLC Recruiting
New London, Connecticut, United States, 06320
Chase Medical Research, LLC Active, not recruiting
Waterbury, Connecticut, United States, 06708
United States, Florida
Meridien Research Recruiting
Bradenton, Florida, United States, 34208
Meridien Research Recruiting
Brooksville, Florida, United States, 34601
Gulfcoast Clinical Research Center Recruiting
Fort Myers, Florida, United States, 33912
MD Clinical Recruiting
Hallandale Beach, Florida, United States, 33009
Palm Beach Neurological Center, Terminated
Palm Beach Gardens, Florida, United States, 33418
Meridien Research Recruiting
St. Petersburg, Florida, United States, 33709
Meridien Research Recruiting
Tampa, Florida, United States, 33606
Clinical Research of Central Florida Recruiting
Winter Haven, Florida, United States, 33880
United States, Georgia
Columbus Research Foundation Recruiting
Columbus, Georgia, United States, 31904
United States, Illinois
Suburban Clinical Research Active, not recruiting
Chicago, Illinois, United States, 60624
Suburban Clinical Research Recruiting
Naperville, Illinois, United States, 60564
United States, Kentucky
Central Kentucky Research Associates, Inc. Recruiting
Lexington, Kentucky, United States, 40509
United States, Louisiana
Arthritis and Diabetes Clinic, Inc. Recruiting
Monroe, Louisiana, United States, 71203
United States, Massachusetts
Miray Medical Center Recruiting
Brockton, Massachusetts, United States, 02301
Beacon Clinical Research, LLC Recruiting
Brockton, Massachusetts, United States, 02301
Genesis Clinical Research, LLC Recruiting
Fall River, Massachusetts, United States, 02720
United States, Michigan
Borgess Research Institute Terminated
Kalamazoo, Michigan, United States, 49048
Borgess Diabetes Center Terminated
Kalamazoo, Michigan, United States, 49048
United States, Missouri
Mercy Health Research Terminated
St. Louis, Missouri, United States, 63141
United States, Nebraska
Quality Clinical Research, Inc. Recruiting
Omaha, Nebraska, United States, 68114
United States, Nevada
Mirkil Medical Group Recruiting
Las Vegas, Nevada, United States, 89119
Clinical Research Consortium Recruiting
Las Vegas, Nevada, United States, 89119
United States, New York
The Medical Research Network, LLC Recruiting
New York, New York, United States, 10128
United States, Ohio
Radiant Research Recruiting
Columbus, Ohio, United States, 43212
United States, Oklahoma
Sooner Clinical Research Recruiting
Oklahoma City, Oklahoma, United States, 73112
The Office of Veronique Sebastian, MD Recruiting
Oklahoma City, Oklahoma, United States, 73120
United States, Oregon
Sunstone Medical Research, LLC Recruiting
Medford, Oregon, United States, 97504
United States, Pennsylvania
Blair Orthopedic Associates, Inc. Recruiting
Altoona, Pennsylvania, United States, 16602
Altoona Center for Clinical Research Recruiting
Duncansville, Pennsylvania, United States, 16635
United States, South Carolina
Neurology and Pain Clinic, LLC Terminated
Orangeburg, South Carolina, United States, 29118
United States, Tennessee
New Phase Research and Development Recruiting
Knoxville, Tennessee, United States, 37919
United States, Texas
University of Texas Southwestern Medical Center at Dallas Recruiting
Dallas, Texas, United States, 75390
Houston Neurocare Recruiting
Houston, Texas, United States, 77030
Centex Research, Inc. Recruiting
Houston, Texas, United States, 77062
Czech Republic
UNARS, s.r.o. Recruiting
Pelhrimov, Czech Republic, 39301
Clintrial, s.r.o. Recruiting
Praha 10, Czech Republic, 100 00
Fakultni nemocnice v Motole Recruiting
Praha 5, Czech Republic, 150 06
Italy
A.O.U. San Martino, DIMI, Dipartimento Medicina Interna e Specialita Mediche, Clinica Gerontologica Not yet recruiting
Genova, Italy, 16132
Dipartimento di Medicina Interna e Specialit�ediche � DI.M.I. Not yet recruiting
Genova, Italy, 16132
IRCCS A.O.U. San Martino � IST Not yet recruiting
Genova, Italy, 16132
U.O. Complessa di Diabetologia e Dietetica � ULSS 16 Not yet recruiting
Padova, Italy, 35143
Universit�egli Studi di Roma La Sapienza Recruiting
Roma, Italy, 00185
Fondazione PTV Policlinico Tor Vergata di Roma Recruiting
Roma, Italy, 00133
Sweden
Forskningsmottagningen Gamla Sjukhuset i Falkoping Recruiting
Falkoping, Sweden, 521 43
Center for Lakemedelsstudier Recruiting
Malmo, Sweden, 211 52
Citydiabetes Recruiting
Stockholm, Sweden, 111 57
Bragee Medect AB Recruiting
Stockholm, Sweden, 115 22
Sponsors and Collaborators
Pfizer
Investigators
Study Director: Pfizer CT.gov Call Center Pfizer
  More Information

Additional Information:
No publications provided

Responsible Party: Pfizer
ClinicalTrials.gov Identifier: NCT01455415     History of Changes
Other Study ID Numbers: A0081268
Study First Received: October 17, 2011
Last Updated: May 16, 2013
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Pain
Peripheral Nervous System Diseases
Diabetic Neuropathies
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Neuromuscular Diseases
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Pregabalin
Therapeutic Uses
Pharmacologic Actions
Analgesics, Non-Narcotic
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Antirheumatic Agents
Central Nervous System Agents
Anticonvulsants

ClinicalTrials.gov processed this record on May 16, 2013